Kristine Joyce L. Porto, Jacqueline Jacqueline, Nilda Munoz, Carmela San Luis, Matthew Reyes, Anna Francesca Robles, Reuel Delicana, Angelo Jamerlan, Deborah Bernardo (St. Luke's Medical Center, Japan)
Session information
Oral Session
[O-36] Neuropathology
Fri. May 24, 2019 9:45 AM - 11:15 AM Room 13 (Osaka International Convention Center 8F Conference Room 801-802)
Chair:Haruhiko Akiyama(Yokohama Brain and Spine Center) Commentator:Mari Yoshida(Institute for Medical Science of Aging, Aichi Medical University)
Fumihiro Yanagimura1, Etsuji Saji1, Takahiro Wakasugi1, Kaori Yanagawa1, Mariko Hokari1, Yasuko Toyoshima2, Akiyoshi Kakita2, Hitoshi Takahashi2, Masatoyo Nishizawa1, Osamu Onodera1, Izumi Kawachi1 (1.Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan, 2.Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan)
Koyo Tsujikawa1, Kohei Hamanaka2, Mari Yoshida3, Kentaro Sahashi1, Satoko Miyatake2, Satomi Mitsuhashi2, Yohei Iguchi1, Yuichi Riku1, Shinsuke Ishigaki1, Gen Sobue4, Naomichi Matsumoto2, Masahisa Katsuno1 (1.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 2.Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3.Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 4.Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine)
Yilin Liu, Yiming Zheng, Qiang Gang, Yiwen Jin, Xiaohui Zhang, Xuerong Deng, Hongjun Hao, Feng Gao, Zhuoli Zhang, Hui Xiong, Wei Zhang, Zhaoxia Wang, Yun Yuan (Peking University First Hospital, China)
Hitoshi Aizawa1,4, Takenari Yamashita2, Haruhisa Kato1,4, Takashi Kimura3, Tomoko Saito1, Sayaka Teramoto4, Takuto Hideyama1,4, Shin Kwak4 (1.Department of Neurology, Tokyo Medical University, Japan, 2.Department of Pathophysiology, Tokyo Medical University, Japan, 3.Department of Neurology, Asahikawa Medical Center, Japan, 4.Department of Neuromolecularpathology, Japan)
Yoshiki Takai1, Tatsuro Misu1,2, Kimihiko Kaneko1, Norio Chihara3, Kouichi Narikawa4, Hiroya Nishida5, Satoko Tsuchida6, Morinobu Seki7, Teppei Komatsu8, Kiyotaka Nakamagome9, Toshiyuki Takahashi1, Hirohiko Ono1, Shuhei Nishiyama1, Hiroshi Kuroda1, Masashi Aoki1, Kazuo Fujihara1,10 (1.Department of Neurology, Tohoku University Hospital, Japan, 2.Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, 3.Department of Neurology, Kobe University Hospital, 4.Department of Neurology, Japanese Red Cross Ishinomaki Hospital, 5.Department of Pediatrics, Tokyo Metropolitan Neurological Hospital, 6.Department of Pediatrics, Japanese Red Cross Akita Hospital, 7.Department of Neurology, Keio University Hospital, 8.Department of Neurology, Jikei University Hospital, 9.Department of Neurology, University of Tsukuba Hospital, 10.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University)